This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Standalone Q2 revenue up 44%; profit after tax of Rs 97.61 lakh versus year-earlier loss
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.6 pts less than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The standalone quarter ended 30 September 2026 versus the same quarter a year earlier had revenue of Rs 2,104.01 lakh, up 44.3% from Rs 1,457.71 lakh, and profit after tax of Rs 97.61 lakh versus a loss of Rs 23.55 lakh. A Rs 81.35 lakh exceptional charge hit Q2. Standalone operating cash flow for the half year ended 30 September 2026 was negative Rs 43.20 lakh. At period end, standalone borrowings were Rs 1,423.18 lakh, 2.01 times equity.
Revenue growth and profit recovery are positive, but negative operating cash flow, the exceptional charge and borrowings at 2.01 times equity add risk.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹21.04 Cr | ₹9.46 Cr | +122.5% |
| Operating profit | ₹1.43 Cr | −₹0.25 Cr | turned positive |
| Profit after tax | ₹0.98 Cr | −₹0.24 Cr | turned positive |
| EBITDA margin | 9.3% | 2.8% | +6.4 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.